Breaking News Instant updates and real-time market news.

BX

Blackstone

$23.84

-0.32 (-1.32%)

, GS

Goldman Sachs

$167.42

-1.88 (-1.11%)

06:06
10/14/16
10/14
06:06
10/14/16
06:06

Blackstone, Apollo expected to bid for Xella, Reuters reports

Blackstone (BX), Apollo (APO) and Bain are among the private equity firms said to hand in "tentative" offers for building materials maker Xella, Reuters reports, citing several people close to the deal. According to the sources, bids by the private equity firms are likely to value Xella at 6 to 7 times Xella's expected annual core earnings of EUR270M, while the sellers -- PAI Partners and Goldman Sachs' (GS) investment arm -- are hoping for a multiple of 8 times. Reference Link

BX

Blackstone

$23.84

-0.32 (-1.32%)

GS

Goldman Sachs

$167.42

-1.88 (-1.11%)

APO

Apollo Global

$18.14

-0.55 (-2.94%)

  • 27

    Oct

  • 28

    Oct

  • 10

    Nov

BX Blackstone
$23.84

-0.32 (-1.32%)

03/11/16
DBAB
03/11/16
DOWNGRADE
Target $28
DBAB
Hold
Blackstone downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded Blackstone (BX) to Hold saying Alternative Asset Mangers will underperform over the next year amid volatile markets. The analyst lowered his price target for the shares to $28 from $30 and views Oaktree Capital (OAK) as the best positioned in the space.
12/14/15
12/14/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Atwood Oceanics (ATW) initiated with a Hold at KLR Group... Axsome Therapies (AXSM) initiated with a Buy at Ladenburg... Blackstone (BX) initiated with an Outperform at William Blair... Build-A-Bear (BBW) initiated with a Neutral at Guggenheim... C&J Energy (CJES) initiated with a Buy at KLR Group... CARBO Ceramics (CRR) initiated with a Hold at KLR Group... Core Laboratories (CLB) initiated with a Buy at KLR Group... Diamond Offshore (DO) initiated with an Accumulate at KLR Group... Dril-Quip (DRQ) initiated with an Accumulate at KLR Group... Duke Realty (DRE) initiated with a Buy at Goldman... FMC Technologies (FTI) initiated with a Buy at KLR Group... Fairmount Santrol (FMSA) initiated with a Hold at KLR Group... Fibria Celulose (FBR) initiated with a Neutral at Goldman... Flotek (FTK) initiated with a Buy at KLR Group... Forum Energy (FET) initiated with a Buy at KLR Group... Four Corners Property Trust (FCPT) initiated with a Buy at Ladenburg... Frank's International (FI) initiated with a Buy at KLR Group... GATX Corp. (GMT) initiated with a Sell at Axiom... Greenbrier (GBX) initiated with an Outperform at Cowen... Haemonetics (HAE) initiated with a Neutral at BTIG... Halliburton (HAL) initiated with an Accumulate at KLR Group... Helmerich & Payne (HP) initiated with a Buy at KLR Group... Inuvo (INUV) initiated with a Buy at Ladenburg... Liberty Media (LMCA) initiated with an Overweight at JPMorgan... Liberty Property (LPT) initiated with a Neutral at Goldman... Luxoft (LXFT) initiated with an Outperform at William Blair... Match Group (MTCH) initiated with a Buy at Deutsche Bank... Mimecast (MIME) initiated with an Overweight at Barclays... Nabors Industries (NBR) initiated with a Buy at KLR Group... National Oilwell (NOV) initiated with a Buy at KLR Group... Newpark Resources (NR) initiated with a Buy at KLR Group... Oceaneering (OII) initiated with an Accumulate at KLR Group... Oil States (OIS) initiated with a Buy at KLR Group... Pacific Drilling (PACD) initiated with a Hold at KLR Group... Patterson-UTI (PTEN) initiated with a Buy at KLR Group... Rowan Companies (RDC) initiated with a Buy at KLR Group... Schlumberger (SLB) initiated with a Buy at KLR Group... Seadrill (SDRL) initiated with a Reduce at KLR Group... Sirius XM (SIRI) initiated with a Neutral at JPMorgan... Spirit Realty (SRC) initiated with a Buy at SunTrust... Square (SQ) initiated with a Buy at Goldman... Superior Energy (SPN) initiated with a Buy at KLR Group... Tesla (TSLA) initiated with a Market Perform at JMP Securities... Transocean (RIG) initiated with a Buy at KLR Group... Trinity Industries (TRN) initiated with an Outperform at Cowen... U.S. Silica (SLCA) initiated with a Hold at KLR Group... VMware (VMW) initiated with a Buy at Gabelli... WashingtonFirst Bankshares (WFBI) initiated with an Outperform at Raymond James... Weatherford (WFT) initiated with an Accumulate at KLR Group... Whitestone REIT (WSR) initiated with a Neutral at SunTrust... Xtera Communications (XCOM) initiated with a Buy at Needham.
02/01/16
JMPS
02/01/16
NO CHANGE
JMPS
Blackstone outlook positive, says JMP Securities
JMP Securities says that Blackstone's underlying business trends improved in Q4, while its overall outlook is positive. The firm thinks pressure from weak markets so far this year will be transitory. It reiterates a $40 price target and Outperform rating on the shares.
03/08/16
03/08/16
NO CHANGE

Deutsche views ending of SunEdison, Vivint deal as potential positive
Deutsche Bank analyst Vishal Shah believes the termination of SunEdison's (SUNE) agreement to acquire Vivint Solar (VSLR) is a potential longer-term positive for SunEdison and TerraForm Power (TERP). The failure may also turn out to be a positive for Vivint in the long run, Shah tells investors in a research note. Investor focus will now shift from near-term liquidity and balance sheet stress for both TerraForm and SunEdison to potential legal ramifications from Vivint and Blackstone (BX), the analyst contends. He believes, however, that the legal impact may not be that significant considering the audit committee investigation and resulting lack of financing availability.
GS Goldman Sachs
$167.42

-1.88 (-1.11%)

07/13/16
BREN
07/13/16
INITIATION
Target $140
BREN
Hold
Goldman Sachs initiated with a Hold at Berenberg
Target $140.
04/19/16
SBSH
04/19/16
NO CHANGE
Target $185
SBSH
Buy
Goldman Sachs offers the best risk/reward under coverage, says Citi
Citi analyst Keith Horowitz said Goldman Sachs offers the best risk/reward under coverage and sees significant leverage for better returns from improved market conditions and increased expense focus. The analyst rates Goldman Sachs a Buy with a $185 price target.
07/13/16
07/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Citi (C) initiated with a Buy, JPMorgan (JPM) initiated with a Sell, Goldman Sachs (GS) and Morgan Stanley (MS) initiated with a Hold at Berenberg. 2. Ingersoll-Rand (IR) initiated with an Outperform at BMO Capital. 3. Incyte (INCY) initiated with an Outperform at RBC Capital. 4. Williams (WMB) reinstated with a Buy at Goldman. 5. E-Trade (ETFC) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Oppenheimer technical analyst upgrades Financials, downgrades Consumer Staples
Oppenheimer technical analyst Ari Wald upgraded the Financials sector to Market Weight and downgraded Consumer Staples to Underweight in next step in the firm's "cyclical rotation road map." Wald identified Ameriprise (AMP), Bank of America (BAC), Citi (C), Goldman Sachs (GS), Lincoln National (LNC) and SunTrust (STI) as six stocks breaking higher that he sees as likely to benefit from internal market rotation.
APO Apollo Global
$18.14

-0.55 (-2.94%)

08/31/16
08/31/16
NO CHANGE

Apollo Global affiliates extend tender offer for Outerwall
Affiliates of certain funds managed by affiliates of Apollo Global (APO) and Outerwall (OUTR) agreed to extend the offering period of Apollo's previously announced cash tender offer to purchase all of the outstanding shares of common stock of Outerwall to 12:00 Midnight, NYC time, on September 22, unless further extended. As of 5:00 P.M., NYC time, on August 31, 4,834,209 shares of common stock of Outerwall were tendered pursuant to the tender offer, which represented approximately 28.1% of the outstanding shares of common stock of Outerwall.
08/08/16
OPCO
08/08/16
NO CHANGE
Target $32
OPCO
Outperform
Oppenheimer sees Rackspace deal in the low-to-mid $30s
Oppenheimer analyst Timothy Horan raised his price target for Rackspace (RAX) to $32 from $30 after The Wall Street Journal reported that the company was in advanced talks to sell itself to Apollo Global (APO) for $3.5B, or $27 per share. The analyst believes this is low and that a deal in the $32 area is more likely. Oppenheimer has an Outperform rating on Rackspace's shares.
08/04/16
08/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Texas Instruments (TXN) upgraded to Neutral from Underperform at Exane BNP Paribas. 2. Spirit Airlines (SAVE) upgraded to Strong Buy from Outperform at Raymond James with analyst Savanthi Syth saying the recent weakness in the shares brings a "very attractive entry point." 3. Archer Daniels (ADM) upgraded to Buy from Hold at Argus with analyst David Coleman citing valuation and management's optimistic outlook for the second half of 2016. 4. Celgene (CELG) upgraded to Buy from Neutral at BTIG. Analyst Dane Leone believes the company's 2020 financial targets are achievable and represent upside to current consensus estimates. 5. Apollo Global (APO) upgraded to Outperform from Perform at Oppenheimer and to Outperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/16
KBWI
08/04/16
UPGRADE
Target $22
KBWI
Outperform
Apollo Global upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee upgraded Apollo Global to Outperform citing strong investment performance and capital formation following the company's Q2 results. The analyst raised his price target for the shares to $22 from $18. Oppenheimer this morning also upgraded Apollo Global.

TODAY'S FREE FLY STORIES

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

19:05
12/04/16
12/04
19:05
12/04/16
19:05
Hot Stocks
Alnylam reports Phase 2 data on fitusiran in hemophilia »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$122.96

0.95 (0.78%)

19:01
12/04/16
12/04
19:01
12/04/16
19:01
Hot Stocks
Alexion reports data from Phase 1/2 ALXN1210 study »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

LYV

Live Nation

$27.07

-0.44 (-1.60%)

18:58
12/04/16
12/04
18:58
12/04/16
18:58
Hot Stocks
Live Nation acquires 51% stake in Australia's Secret Sounds Group »

Live Nation Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$68.17

0.42 (0.62%)

18:45
12/04/16
12/04
18:45
12/04/16
18:45
Hot Stocks
Novartis reports Phase 2 data on CTL019 in leukemia »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ABBV

AbbVie

$59.43

0.27 (0.46%)

, JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

18:29
12/04/16
12/04
18:29
12/04/16
18:29
Hot Stocks
AbbVie reports five-year IMBRUVICA data, updated RESONATE-2 data »

AbbVie (ABBV) announced…

ABBV

AbbVie

$59.43

0.27 (0.46%)

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

CELG

Celgene

$117.63

-1.24 (-1.04%)

18:17
12/04/16
12/04
18:17
12/04/16
18:17
Hot Stocks
Celgene, Dana-Farber, U of Arkansas form Myeloma Genome Project »

Celgene, Dana-Farber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

ARQL

ArQule

$1.37

-0.01 (-0.72%)

18:12
12/04/16
12/04
18:12
12/04/16
18:12
Hot Stocks
ArQule reports data presentation on ARQ 092 in sickle cell disease »

ArQule announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$98.50

-0.44 (-0.44%)

, TWX

Time Warner

$93.80

-0.34 (-0.36%)

18:08
12/04/16
12/04
18:08
12/04/16
18:08
Hot Stocks
Box Office Battle: 'Moana,' 'Fantastic Beasts' win post-Thanksgiving weekend »

Disney's (DIS)…

DIS

Disney

$98.50

-0.44 (-0.44%)

TWX

Time Warner

$93.80

-0.34 (-0.36%)

VIA

Viacom

$40.35

-1 (-2.42%)

VIAB

Viacom

$36.52

-0.74 (-1.99%)

SNE

Sony

$28.06

-0.16 (-0.57%)

FOX

21st Century Fox

$27.37

-0.71 (-2.53%)

FOXA

21st Century Fox

$27.40

-0.8 (-2.84%)

LGF

Lionsgate

$22.72

0.02 (0.09%)

CMCSA

Comcast

$68.78

-1.08 (-1.55%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

17:09
12/04/16
12/04
17:09
12/04/16
17:09
Conference/Events
Starbucks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CS

Credit Suisse

$13.39

-0.34 (-2.48%)

17:03
12/04/16
12/04
17:03
12/04/16
17:03
Conference/Events
Credit Suisse to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

, SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

17:02
12/04/16
12/04
17:02
12/04/16
17:02
Hot Stocks
Takeda Pharma, Seattle Genetics reports Phase 3 ADCETRIS data »

Takeda Pharmaceutical…

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CGEN

Compugen

$5.95

0.1 (1.71%)

16:59
12/04/16
12/04
16:59
12/04/16
16:59
Conference/Events
Compugen to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

QURE

uniQure

$5.68

-0.31 (-5.18%)

16:56
12/04/16
12/04
16:56
12/04/16
16:56
Hot Stocks
uniQure reports data on AMT-060 in hemophilia B »

uniQure announced new and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 08

    Dec

RGLS

Regulus

$2.50

0.1 (4.17%)

16:53
12/04/16
12/04
16:53
12/04/16
16:53
Conference/Events
Regulus to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

PBI

Pitney Bowes

$14.63

0.1 (0.69%)

16:52
12/04/16
12/04
16:52
12/04/16
16:52
Conference/Events
Pitney Bowes to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

16:43
12/04/16
12/04
16:43
12/04/16
16:43
Hot Stocks
Seattle Genetics reports Phase 1b vadastuximab talirine data, plans Ph. 2 trial »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NVS

Novartis

$68.17

0.42 (0.62%)

16:38
12/04/16
12/04
16:38
12/04/16
16:38
Hot Stocks
Novartis reports Phase 2 SEG101 data »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PFE

Pfizer

$31.63

0.17 (0.54%)

16:33
12/04/16
12/04
16:33
12/04/16
16:33
Hot Stocks
Pfizer reports Phase 2 glasdegib data »

Pfizer announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

EKSO

Ekso Bionics

$4.27

-0.11 (-2.51%)

16:30
12/04/16
12/04
16:30
12/04/16
16:30
Conference/Events
Ekso Bionics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ADSK

Autodesk

$70.57

1.35 (1.95%)

16:24
12/04/16
12/04
16:24
12/04/16
16:24
Conference/Events
Autodesk to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Jan

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

16:23
12/04/16
12/04
16:23
12/04/16
16:23
Hot Stocks
Seattle Genetics reports Phase 2 ADCETRIS lymphoma data, says discontinues trial »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FTI

FMC Technologies

$35.60

0.9 (2.59%)

, TKPPY

Technip

$17.80

0.45 (2.59%)

16:21
12/04/16
12/04
16:21
12/04/16
16:21
Conference/Events
Technip to host special shareholder meeting »

Special Shareholder…

FTI

FMC Technologies

$35.60

0.9 (2.59%)

TKPPY

Technip

$17.80

0.45 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TKPPY

Technip

$17.80

0.45 (2.59%)

, FTI

FMC Technologies

$35.60

0.9 (2.59%)

16:14
12/04/16
12/04
16:14
12/04/16
16:14
Conference/Events
FMC Technologies to host special shareholder meeting »

Special Shareholder…

TKPPY

Technip

$17.80

0.45 (2.59%)

FTI

FMC Technologies

$35.60

0.9 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

16:04
12/04/16
12/04
16:04
12/04/16
16:04
Hot Stocks
Alnylam reports interim Phase 1 data on fitusiran »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADRO

Aduro Biotech

$10.80

0.25 (2.37%)

16:01
12/04/16
12/04
16:01
12/04/16
16:01
Hot Stocks
Aduro Biotech reports presentation of BION-1301 data »

Aduro Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.